Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy

globenewswire.com/news-release/2025/07/14/3114584/0/en/Sonnet-BioTherapeutics-Inc-Announces-888-Million-Business-Combination-to-Launch-a-HYPE-Cryptocurrency-Treasury-Reserve-Strategy.html

PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that it has entered into a definitive agreement (the “Business Combination Agreement”, or the “BCA”) for a business combination (the “Business…

This story appeared on globenewswire.com, 2025-07-14 11:27:03.018000.
The Entire Business World on a Single Page. Free to Use →